Adtalem Global Education Q4 2026 Earnings Report

Adtalem Global Education EPS Results

• Actual EPS: $2.09
• Consensus EPS: $1.90
• Beat/Miss: Beat by +$0.19
• One Year Ago EPS: N/A

Adtalem Global Education Revenue Results

• Actual Revenue: $501.38 million
• Expected Revenue: N/A
• Beat/Miss: N/A
• YoY Revenue Growth: N/A

Adtalem Global Education Announcement Details

• Quarter: Q4 2026
• Date: 8/6/2026
• Time: After Market Closes
• Conference Call Date: N/A
• Conference Call Time: N/A

Adtalem Global Education (NYSE:CVSA) (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines. Its services extend beyond degree programs to employer partnerships, customized workforce development, student support services and pathways intended to connect graduates with clinical placements and professional opportunities. Programs are offered in a mix of in-person, hybrid and online formats to serve traditional and nontraditional learners.

Headquartered in the United States, Adtalem serves students and employer partners in the U.S. and select international markets, including Caribbean locations where some medical and veterinary programs maintain campus presence. The company traces its roots to a longstanding provider of postsecondary education and adopted the Adtalem Global Education name following a corporate rebranding; it continues to emphasize career-focused education and workforce alignment as core elements of its strategy.